Literature DB >> 9619538

Attitudes about genetic risk of couples undergoing in-vitro fertilization.

L R Schover1, A J Thomas, T Falcone, M Attaran, J Goldberg.   

Abstract

Many couples undergoing in-vitro fertilization (IVF) are at a higher risk of having a child with a genetic abnormality. In a sample of 55 consecutive couples starting IVF, only 33% had no genetic risk factor. The most common genetic risks were advanced maternal age and possible abnormalities associated with severe male infertility. Despite education on these risks, 71% of couples had no interest in receiving formal genetic counselling. Only 14% of couples at risk would consider using a gamete donor to avoid transmitting a genetic disorder to a child. The triple test to screen for fetal abnormalities was acceptable to 82% of couples, but only 47% planned to have amniocentesis or chorionic villi sampling. Couples were significantly more likely to opt for prenatal testing if they would consider terminating a pregnancy should the fetus have a severe genetic abnormality (P < 0.01). Roman Catholic couples tended to have more conservative attitudes about pregnancy termination. Socio-economic status and whether the infertility factor was male or female were not predictors of a couple's attitudes.

Entities:  

Keywords:  Empirical Approach; Genetics and Reproduction

Mesh:

Year:  1998        PMID: 9619538     DOI: 10.1093/humrep/13.4.862

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  3 in total

1.  Male partners' role in Latinas' amniocentesis decisions.

Authors:  Carole H Browner; H Mabel Preloran
Journal:  J Genet Couns       Date:  1999-04       Impact factor: 2.537

2.  Invasive prenatal testing decisions in pregnancy after infertility.

Authors:  Colleen Caleshu; Shoshana Shiloh; Cristofer Price; Julie Sapp; Barbara Biesecker
Journal:  Prenat Diagn       Date:  2010-06       Impact factor: 3.050

3.  When to ask male adolescents to provide semen sample for fertility preservation?

Authors:  Ali A Dabaja; Matthew S Wosnitzer; Alexander Bolyakov; Peter N Schlegel; Darius A Paduch
Journal:  Transl Androl Urol       Date:  2014-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.